Radiopharm Theranostics Limited Sponsored ADR RADX 深 沪
等待开盘 05-18 09:30:00 美东时间
4.71
-0.020
-0.42%
华盛通- 最 高4.78
- 今 开4.49
- 成交量 7.32万股
- 最 低 4.46
- 昨 收 4.73
- 总市值 5564.42万
- 52周最高 16.25
- 市盈率 静 --
- 换手率 0.62%
- 52周最低 3.62
- 委 比 -19.81%
- 总股本 1181.41万
- 历史最高 50.82
- 量 比 0.89
- 振 幅 6.77%
- 历史最低 3.4962
- 每 手 1
- 风险率 0.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Radiopharm Theranostics Issues Business Update
Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical
04-23 19:08
Radiopharm Announces Dosing Of Final Patient In Phase 2b Imaging Trial Evaluating RAD 101 In Individuals With Confirmed Recurrent Brain Metastases From Solid Tumors Of Different Origins
The U.S. multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic performance of 18F-RAD101 in 30 individuals with confirmed recurrent brain metastases from solid tumors of different
04-16 19:04
Radiopharm Theranostics Advances Cancer Drug Trial After Safety Review
Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical
04-08 19:05
Radiopharm Director Adjusts Share and Option Holdings
Radiopharm Theranostics Limited ( ($AU:RAD) ) has shared an announcement. Radio...
03-31 13:07
Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results
Radiopharm Theranostics says Phase 2b interim data showing 90% MRI concordance for RAD 101, with final readout expected by June.
03-24 22:56
Radiopharm Drug Shows 90% Accuracy In Detecting Brain Tumors In Trial
Radiopharm Theranostics (ASX: RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today
03-24 19:14
美股夜盘 | Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨76.68%，Epsium Enterprise涨20.73%
Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨76.68%；Epsium Enterprise涨20.73%；网络齿轮通信涨14.73%
03-24 09:03
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
An update from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. ...
03-24 06:48
Radiopharm Theranostics Doses First Participant In Phase 1/2 Clinical Study Of 177Lu-Betabart
Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today
02-24 20:36
